Coloplast A/S

CPSE:COLO B Stock Report

Market Cap: kr.202.5b

Coloplast Management

Management criteria checks 4/4

Coloplast's CEO is Kristian Villumsen, appointed in Dec 2018, has a tenure of 5.33 years. total yearly compensation is DKK23.30M, comprised of 51.5% salary and 48.5% bonuses, including company stock and options. directly owns 0.045% of the company’s shares, worth DKK91.24M. The average tenure of the management team and the board of directors is 6 years and 6.3 years respectively.

Key information

Kristian Villumsen

Chief executive officer

kr.23.3m

Total compensation

CEO salary percentage51.5%
CEO tenure5.3yrs
CEO ownership0.05%
Management average tenure6yrs
Board average tenure6.3yrs

Recent management updates

Here's Why We Think Coloplast A/S' (CPH:COLO B) CEO Compensation Looks Fair for the time being

Nov 25
Here's Why We Think Coloplast A/S' (CPH:COLO B) CEO Compensation Looks Fair for the time being

Recent updates

There's Reason For Concern Over Coloplast A/S' (CPH:COLO B) Price

Apr 08
There's Reason For Concern Over Coloplast A/S' (CPH:COLO B) Price

Is Coloplast (CPH:COLO B) A Risky Investment?

Mar 21
Is Coloplast (CPH:COLO B) A Risky Investment?

Estimating The Intrinsic Value Of Coloplast A/S (CPH:COLO B)

Jan 09
Estimating The Intrinsic Value Of Coloplast A/S (CPH:COLO B)

Coloplast A/S' (CPH:COLO B) Price Is Out Of Tune With Earnings

Dec 22
Coloplast A/S' (CPH:COLO B) Price Is Out Of Tune With Earnings

These 4 Measures Indicate That Coloplast (CPH:COLO B) Is Using Debt Reasonably Well

Dec 04
These 4 Measures Indicate That Coloplast (CPH:COLO B) Is Using Debt Reasonably Well

Coloplast (CPH:COLO B) Strong Profits May Be Masking Some Underlying Issues

Nov 16
Coloplast (CPH:COLO B) Strong Profits May Be Masking Some Underlying Issues

A Look At The Intrinsic Value Of Coloplast A/S (CPH:COLO B)

Sep 30
A Look At The Intrinsic Value Of Coloplast A/S (CPH:COLO B)

Is Coloplast (CPH:COLO B) A Risky Investment?

Jun 28
Is Coloplast (CPH:COLO B) A Risky Investment?

Coloplast A/S' (CPH:COLO B) Intrinsic Value Is Potentially 18% Below Its Share Price

Jun 10
Coloplast A/S' (CPH:COLO B) Intrinsic Value Is Potentially 18% Below Its Share Price

Coloplast (CPH:COLO B) Seems To Use Debt Quite Sensibly

Mar 22
Coloplast (CPH:COLO B) Seems To Use Debt Quite Sensibly

Coloplast A/S' (CPH:COLO B) Intrinsic Value Is Potentially 25% Below Its Share Price

Mar 01
Coloplast A/S' (CPH:COLO B) Intrinsic Value Is Potentially 25% Below Its Share Price

These 4 Measures Indicate That Coloplast (CPH:COLO B) Is Using Debt Reasonably Well

Dec 14
These 4 Measures Indicate That Coloplast (CPH:COLO B) Is Using Debt Reasonably Well

Coloplast's (CPH:COLO B) Upcoming Dividend Will Be Larger Than Last Year's

Nov 26
Coloplast's (CPH:COLO B) Upcoming Dividend Will Be Larger Than Last Year's

Here's Why We Think Coloplast A/S' (CPH:COLO B) CEO Compensation Looks Fair for the time being

Nov 25
Here's Why We Think Coloplast A/S' (CPH:COLO B) CEO Compensation Looks Fair for the time being

Coloplast's (CPH:COLO B) Shareholders Will Receive A Bigger Dividend Than Last Year

Nov 11
Coloplast's (CPH:COLO B) Shareholders Will Receive A Bigger Dividend Than Last Year

With EPS Growth And More, Coloplast (CPH:COLO B) Makes An Interesting Case

Oct 25
With EPS Growth And More, Coloplast (CPH:COLO B) Makes An Interesting Case

Estimating The Fair Value Of Coloplast A/S (CPH:COLO B)

Aug 26
Estimating The Fair Value Of Coloplast A/S (CPH:COLO B)

These 4 Measures Indicate That Coloplast (CPH:COLO B) Is Using Debt Reasonably Well

Jul 27
These 4 Measures Indicate That Coloplast (CPH:COLO B) Is Using Debt Reasonably Well

Here's Why We Think Coloplast (CPH:COLO B) Is Well Worth Watching

Jul 12
Here's Why We Think Coloplast (CPH:COLO B) Is Well Worth Watching

Is There An Opportunity With Coloplast A/S' (CPH:COLO B) 45% Undervaluation?

May 23
Is There An Opportunity With Coloplast A/S' (CPH:COLO B) 45% Undervaluation?

Coloplast (CPH:COLO B) Is Due To Pay A Dividend Of kr.5.00

May 08
Coloplast (CPH:COLO B) Is Due To Pay A Dividend Of kr.5.00

Coloplast (CPH:COLO B) Seems To Use Debt Rather Sparingly

Apr 13
Coloplast (CPH:COLO B) Seems To Use Debt Rather Sparingly

Here's Why I Think Coloplast (CPH:COLO B) Is An Interesting Stock

Mar 29
Here's Why I Think Coloplast (CPH:COLO B) Is An Interesting Stock

Coloplast A/S (CPH:COLO B) Shares Could Be 41% Below Their Intrinsic Value Estimate

Feb 12
Coloplast A/S (CPH:COLO B) Shares Could Be 41% Below Their Intrinsic Value Estimate

Coloplast (CPH:COLO B) Could Easily Take On More Debt

Jan 12
Coloplast (CPH:COLO B) Could Easily Take On More Debt

Is Now The Time To Put Coloplast (CPH:COLO B) On Your Watchlist?

Dec 28
Is Now The Time To Put Coloplast (CPH:COLO B) On Your Watchlist?

Why We Think Coloplast A/S' (CPH:COLO B) CEO Compensation Is Not Excessive At All

Nov 25
Why We Think Coloplast A/S' (CPH:COLO B) CEO Compensation Is Not Excessive At All

A Look At The Fair Value Of Coloplast A/S (CPH:COLO B)

Oct 31
A Look At The Fair Value Of Coloplast A/S (CPH:COLO B)

Here's Why Coloplast (CPH:COLO B) Can Manage Its Debt Responsibly

Oct 02
Here's Why Coloplast (CPH:COLO B) Can Manage Its Debt Responsibly

Do Coloplast's (CPH:COLO B) Earnings Warrant Your Attention?

Sep 16
Do Coloplast's (CPH:COLO B) Earnings Warrant Your Attention?

Does This Valuation Of Coloplast A/S (CPH:COLO B) Imply Investors Are Overpaying?

Aug 02
Does This Valuation Of Coloplast A/S (CPH:COLO B) Imply Investors Are Overpaying?

Coloplast (CPH:COLO B) Seems To Use Debt Quite Sensibly

Jul 01
Coloplast (CPH:COLO B) Seems To Use Debt Quite Sensibly

Does Coloplast (CPH:COLO B) Deserve A Spot On Your Watchlist?

Jun 16
Does Coloplast (CPH:COLO B) Deserve A Spot On Your Watchlist?

Coloplast A/S (CPH:COLO B) Shares Could Be 34% Above Their Intrinsic Value Estimate

May 02
Coloplast A/S (CPH:COLO B) Shares Could Be 34% Above Their Intrinsic Value Estimate

Would Coloplast A/S (CPH:COLO B) Be Valuable To Income Investors?

Apr 11
Would Coloplast A/S (CPH:COLO B) Be Valuable To Income Investors?

Here's Why Coloplast (CPH:COLO B) Can Manage Its Debt Responsibly

Mar 29
Here's Why Coloplast (CPH:COLO B) Can Manage Its Debt Responsibly

Will Weakness in Coloplast A/S' (CPH:COLO B) Stock Prove Temporary Given Strong Fundamentals?

Mar 16
Will Weakness in Coloplast A/S' (CPH:COLO B) Stock Prove Temporary Given Strong Fundamentals?

I Built A List Of Growing Companies And Coloplast (CPH:COLO B) Made The Cut

Mar 02
I Built A List Of Growing Companies And Coloplast (CPH:COLO B) Made The Cut

Did You Participate In Any Of Coloplast's (CPH:COLO B) Fantastic 123% Return ?

Feb 17
Did You Participate In Any Of Coloplast's (CPH:COLO B) Fantastic 123% Return ?

What Percentage Of Coloplast A/S (CPH:COLO B) Shares Do Insiders Own?

Feb 03
What Percentage Of Coloplast A/S (CPH:COLO B) Shares Do Insiders Own?

CEO Compensation Analysis

How has Kristian Villumsen's remuneration changed compared to Coloplast's earnings?
DateTotal CompensationSalaryCompany Earnings
Dec 31 2023n/an/a

kr.5b

Sep 30 2023kr.23mkr.12m

kr.5b

Jun 30 2023n/an/a

kr.5b

Mar 31 2023n/an/a

kr.5b

Dec 31 2022n/an/a

kr.5b

Sep 30 2022kr.21mkr.12m

kr.5b

Jun 30 2022n/an/a

kr.5b

Mar 31 2022n/an/a

kr.5b

Dec 31 2021n/an/a

kr.5b

Sep 30 2021kr.22mkr.11m

kr.5b

Jun 30 2021n/an/a

kr.5b

Mar 31 2021n/an/a

kr.4b

Dec 31 2020n/an/a

kr.4b

Sep 30 2020kr.20mkr.11m

kr.4b

Jun 30 2020n/an/a

kr.4b

Mar 31 2020n/an/a

kr.4b

Dec 31 2019n/an/a

kr.4b

Sep 30 2019kr.17mkr.10m

kr.4b

Jun 30 2019n/an/a

kr.4b

Mar 31 2019n/an/a

kr.4b

Dec 31 2018n/an/a

kr.4b

Sep 30 2018kr.11mkr.6m

kr.4b

Jun 30 2018n/an/a

kr.4b

Mar 31 2018n/an/a

kr.4b

Dec 31 2017n/an/a

kr.4b

Sep 30 2017kr.10mkr.6m

kr.4b

Compensation vs Market: Kristian's total compensation ($USD3.33M) is about average for companies of similar size in the Danish market ($USD4.16M).

Compensation vs Earnings: Kristian's compensation has been consistent with company performance over the past year.

CEO

Kristian Villumsen (53 yo)

5.3yrs

Tenure

kr.23,300,000

Compensation

Mr. Kristian Villumsen has been Independent Director of Demant A/S since March 5, 2021. He has been the President and Chief Executive Officer of Coloplast A/S since December 4, 2018. Mr. Villumsen was an E...

Leadership Team

NamePositionTenureCompensationOwnership
Kristian Villumsen
President & CEO5.3yrskr.23.30m0.045%
DKK 91.2m
Anders Lonning-Skovgaard
Executive VP & CFO9.8yrskr.11.90m0.0012%
DKK 2.4m
Allan Rasmussen
Executive Vice President of Global Operations9.8yrskr.10.50m0%
DKK 0
Nicolai Andersen
Executive Vice President of Innovationno datakr.10.00mno data
Paul Marcun
Executive Vice President of Growth5.3yrskr.12.00mno data
Thomas Barfod
Senior Controller & Employees Representative Directorno datakr.450.00k0.000020%
DKK 40.5k
Ellen Bjurgert
Vice President of Investor Relations7.5yrsno datano data
Dennis Kaysen
Director of Corporate Communicationsno datano datano data
Dorthe Ronnau
Senior Vice President of People & Culture2.3yrsno datano data
Alain Morvan
Senior Vice President of Sales Europe12yrsno datano data
Rasmus Møller
Senior Vice President of Wound & Skin Care3.6yrsno datano data
Manu Varma
Senior Vice President of Chronic Care - North America6yrsno datano data

6.0yrs

Average Tenure

54yo

Average Age

Experienced Management: COLO B's management team is seasoned and experienced (6 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Thomas Barfod
Senior Controller & Employees Representative Director18.3yrskr.450.00k0.000020%
DKK 40.5k
Carsten Hellmann
Independent Director6.3yrskr.690.00k0.0027%
DKK 5.4m
Lars Rasmussen
Chairman of the Board5.3yrskr.1.84m0.092%
DKK 186.8m
Niels Louis-Hansen
Deputy Chairman56.3yrskr.938.00k1.93%
DKK 3.9b
Marianne Wiinholt
Independent Director3.3yrskr.880.00k0.00022%
DKK 445.5k
Jette Nygaard-Andersen
Independent Director8.3yrskr.600.00kno data
Nikolaj Gundersen
Employees Representative Director6.3yrskr.450.00kno data
Roland Pedersen
Employees Representative Director6.3yrskr.450.00k0.00072%
DKK 1.5m
Annette Bruls
Independent Director2.3yrskr.600.00kno data

6.3yrs

Average Tenure

58yo

Average Age

Experienced Board: COLO B's board of directors are considered experienced (6.3 years average tenure).

Simply Wall St™
Simply Wall Street Pty Ltd
Level 7, 320 Pitt Street, Sydney
Download on the App StoreGet it on Google Play
Popular Markets
USAUUKINCAZA
About UsCareersPlansLogin
Help CenterLatest CoveragePodcastsAffiliate ProgramBusiness & Enterprise
Financial Services GuideTerms and ConditionsPrivacy PolicyLogos provided by Clearbit
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.